A newer class of drugs that target pancreatic cancer may get a helping hand from an old treatment workhorse: chemotherapy. Two new studies in mice show that adding chemotherapy to an experimental KRAS inhibitor called MRTX1133 greatly reduced tumor growth and spread compared with either treatment alone. https://go.nih.gov/B0kTZ2I
David Rupp
10h
Fascinating - fingers crossed these treatments continue to perform as they progress.
Wonderful! A holistic approach with combinational therapy is the way to go.
Zeer informatief
Digital Transformation & Business Analytics Consultant | MBA in Marketing & Analytics
2hSo exciting to finally see us embarking on the sum greater than parts magic and mechanisms in synergies with interventions and therapies Think there probably will be a number of past studies approaches experiments and analyses that are like low hanging fruit dusted off leveraged with AI diagnostics and precision and all the Constellations that shift the whole picture Often such things are investigated explored and so forth by very smart people for smart reasons and the studies at those times with those limitations and the lack of all these other paradigm and possibility transforming potentiations - everything changes and merits revisiting in the studies as they deemed as fixed and not differentiating to outcomes many things which now are all in play Exciting times ahead revisiting reevaluating and reimagining potentials and possibilities